Jin Lü

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Jin Lü, Yuxian Bai, Teng Mao et al. · JAMA · 2021 · 801 citations · Full text

Medicine, Oncology, Pharmacology +17

The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension

Jiaming Xiu, Xueqin Lin, Qiansheng Chen et al. · Frontiers in Cardiovascular Medicine · 2023 · 92 citations · Full text

Veterinary Medicine, Internal Medicine, Epidemiologic Methods +14

ESCORT-1st: A randomized, double-blind, placebo-controlled, phase 3 trial of camrelizumab plus chemotherapy versus chemotherapy in patients with untreated advanced or metastatic esophageal squamous cell carcinoma (ESCC).

Rui‐Hua Xu, Jin Lü, Yuxian Bai et al. · Journal of Clinical Oncology · 2021 · 63 citations

Medicine, Oncology, Pharmacology +16

Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature

Changchuan Pan, Jin Lü, Jingrui Yu et al. · Experimental and Therapeutic Medicine · 2012 · 54 citations · Full text

Medicine, Oncology, Surgery +17

Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999–2018

Jiabin Tu, Bo Wu, Jiaming Xiu et al. · Frontiers in Physiology · 2023 · 52 citations · Full text

Medicine, Oncology, Cancer Epidemiology +10